Singapore markets closed
Straits Times Index
3,385.93 +1.64 (+0.05%) S&P 500
4,136.48 -43.28 (-1.04%) Dow
33,926.01 -127.89 (-0.38%) Nasdaq
12,006.96 -193.84 (-1.59%) BTC-USD
22,800.93 -589.45 (-2.52%) CMC Crypto 200
523.69 -13.17 (-2.45%)
Horizon Therapeutics Public Limited Company (HZNP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
Pre-market:
| Previous close | 109.79 |
| Open | 109.75 |
| Bid | 77.00 x 900 |
| Ask | 110.49 x 900 |
| Day's range | 109.55 - 110.26 |
| 52-week range | 57.84 - 117.49 |
| Volume | |
| Avg. volume | 4,228,873 |
| Market cap | 25.05B |
| Beta (5Y monthly) | 1.18 |
| PE ratio (TTM) | 44.77 |
| EPS (TTM) | 2.45 |
| Earnings date | 01 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 116.14 |
- Business Wire
Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2022 Financial Results on March 1, 2023
DUBLIN, January 30, 2023--Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its fourth-quarter and full-year 2022 financial results on Wednesday, March 1, 2023, prior to the open of U.S. financial markets.
- Business Wire
Rule 15 (c) Announcement – Horizon Therapeutics plc
DUBLIN, January 27, 2023--Horizon Therapeutics plc (NASDAQ: HZNP):
- Business Wire
Rule 17 (b) Announcement – Horizon Therapeutics plc
DUBLIN, January 23, 2023--Horizon Therapeutics plc (NASDAQ: HZNP):
© 2023 Yahoo. All rights reserved.
